IRadimed Stock

IRadimed ROE

The Return on Equity (ROE) of IRadimed (IRMD) as of Aug 15, 2026 is 23.76 %. In the previous year, Return on Equity (ROE) was 22.15 % — a change of 7.24% (higher).

ROE

23.76 %

YoY

7.24%

Last updated:

In 2026, IRadimed's return on equity (ROE) was 23.76 %, a 7.24% increase from the 22.15 % ROE in the previous year.

Access this data via the Eulerpool API

IRadimed Stock analysis

What does IRadimed do? IRadimed Corp is an American company specializing in the development, manufacturing, and marketing of advanced medical technology products. The company was founded in 1992 and is headquartered in Winter Springs, Florida. It was founded to meet the need for advanced and precise medical devices used in intensive care. In recent years, the company has focused on the development of components and accessory products for magnetic resonance imaging (MRI) used in radiology and oncology. IRadimed Corp is known for its innovative and technologically advanced approach to the medical technology industry. The company prioritizes research and development and collaborates closely with clinics, hospitals, and medical facilities to provide the best solutions for patient care. It has a strong distribution network that allows its products to be distributed worldwide, particularly in the United States, Europe, and Asia. The company offers a wide range of medical devices and accessory products used in radiology, oncology, and other medical fields. Its specialty lies in manufacturing components and accessories for MRI. These include MRI-compatible infusion pumps, patient monitoring devices, ventilation devices, and coil arrays designed for imaging the skull and spine, as well as breast and prostate imaging. In summary, IRadimed Corp is a leading provider of medical devices and accessories for radiology, oncology, and other specialized fields. Its focus on MRI-compatible devices and accessories, as well as its collaborative approach with medical facilities, sets it apart in the industry. The company prides itself on innovation and technological advancement, offering a wide range of products tailored to the needs of patients and medical professionals. IRadimed is one of the most popular companies on Eulerpool.

ROE Details

Decoding IRadimed's Return on Equity (ROE)

IRadimed's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing IRadimed's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

IRadimed's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in IRadimed’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about IRadimed stock

Return on Equity (ROE) of IRadimed is 23.76 % in 2026.

Return on Equity (ROE) of IRadimed changed from 22.15 % to 23.76 %, representing a 7.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) IRadimed since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s IRadimed with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

Profitability — IRadimed

All Key Metrics — IRadimed